Interested in doing a postdoc in my lab in Strasbourg or at @GustaveRoussy under this program? Get in touch! Application deadline: 10.09.25.
https://t.co/22dqfCL03T
This is an interesting use of a miRNA as a protein recruiting element in a degrader to take out Lin28. Delivery challenges always the issue with this type of thing, but still pretty neat.
https://t.co/eZPyGbgzi3
Out now in @natrevbioeng
EPR Effect vs. ATR Principle
How do nanoparticles accumulate in tumors? Not surprisingly, the answer is “it depends”. On the intrinsic leakiness of the tumor and on the type of nanoparticle used.
Check out the full comment👇
https://t.co/68uQnj4MRo
ABSTRACTS SUBMITION is open now on: https://t.co/5kD2aMTQkF
We are waiting for you :)
Fell free to contact us on our social media or email ([email protected]) for further inquiries !!
Our latest work reviewing the landscape of subcutaneous administration of mAbs in oncology in
@AdvSciNews
#AdvMaterials is now published - Congrats to Guillaume et al & thanks to our funding agencies
@ERC_Research#FFRMG @IMStrasbourg @AgenceRecherche -
https://t.co/QxN1Jxe69g
First up in this session, @pottslab showed two nice examples of proximity induction that do not lead to degradation: a KIF18A-tubulin stabilizing molecular glue and a "LOCKTAC" that plugs up PRMT5 with MTA.
📢 Save the date !! Join us for an enlightening webinar on PEG alternatives for Nanoparticles!
🗓️ Date: 29th of March 2024
🕒 Time: 2:00 CEST
🔗 Register here: https://t.co/JAUPOctJ1Y
Such an elegant idea from the Gray lab! Target two nucleophiles simultaneously to reduce the probability of resistance mutation formation. Dielectrophiles were previously reported, but to my knowledge not in the context of avoiding resistance. Very cool.
https://t.co/d3Ja0jJNuK
Thank you to la Ligue CCIR Est and Cancéropôle Est for this nice forum and the poster award on our work on targeting multiple myeloma. Great teamwork between https://t.co/SGCMdrvpUr @AlxDetappe and Loïc Charbonniere from @SynpaTeam @IPHC_Strasbourg#ICANS
2ème matinée de notre 13ème Forum : une première session de communications sélectionnées, suivi par une session sur les développements technologiques en immunothérapie introduite par Hervé Watier (Tours)
#Forum2023
2ème matinée de notre 13ème Forum : une première session de communications sélectionnées, suivi par une session sur les développements technologiques en immunothérapie introduite par Hervé Watier (Tours)
#Forum2023
Many thanks to Dr. Roy van der Meel @rvdmnanomeds and David Schrijver @dvds94 for the exciting talks about the role of #nanotechnology in #immunomodulation. Looking forward to seeing your published work that was discussed today 👏👏
📢 Join us for an enlightening webinar on Trained Immunity using Nanotherapeutics with Dr. Roy van der Meel and David Schrijver.
🗓️ Date: 23 October 2023
🕒 Time: 4:00 CEST
🔗 Register here: https://t.co/xvSBUQlg6Z
#SFNanoJR_1st_webinar@SFNano_official
Glad our review on Ultrasmall NPs to target tumour selected as cover (DOI: 10.1002/adtp.202300019)
Credit to Lena (not on twitter) for design & excellent collaboration between https://t.co/AY08P23FCL & Tillement Group (@iLM_RECHERCHE)
@alxdetappe @AdvSciNews @ERC_Research - #ICANS